← Leaderboards
Richard Weisbart
University Of California Los Angeles
$482,111
Attributed
$1,096,519
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $350.2K · FY2009–16$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$1,096,519 · 3
VA$0 · 1
By mechanism
R21$1,005,782 · 2
R29$90,737 · 1
I01$0 · 1
Top collaborators
- Robert Nishimura3 shared
- Missag Hagop Parseghian3 shared
- Dustin Armstrong2 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Peter K Gin$94,772
- Michelle Parvatiyar$100,588
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsSmall MoleculeBaseIntracellular TransportBinding (Molecular Function)Pathway InteractionsNucleosidesExtracellularInnovationIn VitroMissionAntibodiesToxic EffectIn VivoSpecificityTreatment EfficacyProductionPublic Health RelevanceMediatingInjuryHeat-Shock Proteins 70IndustryClinical TrialsCancer Cell
Grant awards (9)
Targeting MDM2 with Intracellular Antibodies$0
I01 · FY2016 · VA · contact PI
Targeting MDM2 with Intracellular Antibodies$0
I01 · FY2015 · VA · contact PI
Intracellular targeting Hsp70 for pulmonary cytoprotection after toxin inhalation$300,186
R21 · FY2014 · ES
Intracellular targeting Hsp70 for pulmonary cytoprotection after toxin inhalation$50,000
R21 · FY2014 · ES
Targeting MDM2 with Intracellular Antibodies$0
I01 · FY2014 · VA · contact PI
Intracellular targeting Hsp70 for pulmonary cytoprotection after toxin inhalation$318,914
R21 · FY2013 · ES
Intravenous Protein Therapy for Myotonic Dystrophy Type 1$195,590
R21 · FY2010 · NS
Intravenous Protein Therapy for Myotonic Dystrophy Type 1$141,092
R21 · FY2009 · NS
MECHANISM OF AUTOANTIBODY ENTRY INTO CELLS AND NUCLEI$90,737
R29 · FY2000 · DK